GleamWall
中文EN

OM Outset Medical, Inc.

Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 1484612 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY1.6%
TTM net income YoY19.0%
TTM EPS YoY67.5%
Revenue 3-yr CAGR-2.6%
Net income 3-yr CAGR—

Margins

Gross margin42.0%
Operating margin-51.2%
Net margin-58.3%
FCF margin-35.2%
EBITDA margin-48.8%

Returns

ROE-63.0%
ROA-28.0%
ROIC (approx.)-28.3%
Asset turnover0.48x

Leverage & solvency

Liabilities / assets63.8%
Debt / equity1.18x
Current ratio4.86x
Interest coverage-4.54x

Cash quality & payout

Operating cash flow / net income0.60x
Accruals ratio-11.3%
Payout ratio—
Capex / revenue0.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$33.60M$31.64M$27.86M$28.87M$29.43M$31.42M$29.75M$29.47M
Cost of revenue$19.93M$18.35M$15.77M$16.64M$17.84M$19.55M$18.69M$18.72M
Gross profit$13.67M$13.28M$12.10M$12.23M$11.59M$11.87M$11.07M$10.75M
R&D expense$5.90M$5.45M$5.62M$5.05M$5.38M$5.29M$5.51M$7.89M
SG&A expense$8.31M$11.36M$10.12M$11.93M$8.48M$9.16M$8.30M$9.27M
Operating income-$12.27M-$15.68M-$16.92M-$17.63M-$15.81M-$16.86M-$16.40M-$21.86M
Interest expense$3.50M$3.44M$3.37M$3.44M$3.48M$3.48M$3.56M$5.83M
Pretax income-$14.53M-$17.76M-$18.76M-$19.40M-$17.43M-$18.44M-$25.67M-$25.64M
Income tax$153,000$220,000$217,000$95,000$404,000$104,000$115,000-$4,000
Net income-$14.69M-$17.98M-$18.98M-$19.49M-$17.84M-$18.54M-$25.78M-$25.64M
EBITDA-$11.60M-$15.05M-$16.12M-$16.75M-$14.80M-$15.71M-$15.11M-$20.45M
EPS (basic)-0.78-0.97-1.03—-1.00-1.04-3.66—
EPS (diluted)-0.78-0.97-1.03—-1.00-1.04-3.66—
Weighted avg. shares (diluted)18,83118,61918,373—17,78317,7437,038—
Balance sheet
Cash & equivalents$33.94M$35.01M$30.56M$35.01M$36.44M$39.56M$75.93M$124.01M
Short-term investments$102.69M$112.19M$126.14M$133.94M$142.20M$144.53M$113.07M$34.67M
Receivables$30.41M$29.22M$25.32M$28.33M$32.96M$34.89M$36.89M$35.62M
Inventory$44.99M$47.31M$49.65M$47.61M$49.29M$52.25M$55.77M$59.39M
Current assets$216.22M$227.85M$236.71M$250.88M$265.37M$275.58M$286.56M$258.22M
PP&E, net$3.54M$3.71M$4.07M$4.67M$5.25M$6.17M$6.94M$8.13M
Total assets$230.41M$242.38M$249.45M$264.50M$277.25M$288.80M$301.21M$275.80M
Current liabilities$44.45M$43.89M$37.61M$37.63M$37.45M$36.91M$34.22M$45.38M
Long-term debt$98.37M$97.65M$96.94M$96.24M$95.52M$94.81M$94.11M$197.38M
Total debt$98.37M$97.65M$96.94M$96.24M$95.52M$94.81M$94.11M$197.38M
Total liabilities$147.09M$146.05M$137.77M$137.54M$134.89M$134.02M$131.34M$248.98M
Shareholders' equity$83.31M$96.34M$111.69M$126.95M$142.37M$154.78M$169.87M$26.82M
Net debt$64.43M$62.64M$66.38M$61.23M$59.09M$55.26M$18.19M$73.36M
Shares outstanding18.87M18.80M18.53M18.17M17.81M17.77M17.72M3.53M
Cash flow statement
Operating cash flow-$10.38M-$9.63M-$12.84M-$9.52M-$6.32M-$4.82M-$25.66M-$16.49M
Capital expenditure$109,000$111,000$65,000$223,000$160,000$292,000$123,000$43,000
Free cash flow-$10.49M-$9.75M-$12.91M-$9.74M-$6.48M-$5.12M-$25.79M-$16.53M
Investing cash flow$9.66M$14.17M$7.90M$8.59M$2.97M-$31.16M-$78.08M$108.15M
Financing cash flow-$56,000-$88,000$501,000$0$231,000-$384,000$55.66M-$938,000
Depreciation & amortization$666,000$627,000$795,000$881,000$1.01M$1.16M$1.29M$1.41M
Stock-based compensation$1.69M$2.70M$3.45M$4.06M$5.08M$3.50M$2.98M$4.95M

Free plan shows the latest 8 periods; Pro shows all 31 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.